nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—Prothrombin time shortened—Riluzole—amyotrophic lateral sclerosis	0.0489	0.084	CcSEcCtD
Felbamate—GRIN2B—nerve—amyotrophic lateral sclerosis	0.0217	0.133	CbGeAlD
Felbamate—GRIN2A—nerve—amyotrophic lateral sclerosis	0.0189	0.116	CbGeAlD
Felbamate—GRIN2B—hindbrain—amyotrophic lateral sclerosis	0.0162	0.0994	CbGeAlD
Felbamate—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0247	CcSEcCtD
Felbamate—GRIN2A—hindbrain—amyotrophic lateral sclerosis	0.0142	0.0868	CbGeAlD
Felbamate—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0227	CcSEcCtD
Felbamate—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.013	0.0223	CcSEcCtD
Felbamate—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—GRIA2—amyotrophic lateral sclerosis	0.0124	0.0488	CbGpPWpGaD
Felbamate—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0207	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of CaMKII—NEFL—amyotrophic lateral sclerosis	0.0109	0.0431	CbGpPWpGaD
Felbamate—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—amyotrophic lateral sclerosis	0.0109	0.0431	CbGpPWpGaD
Felbamate—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—GRIA2—amyotrophic lateral sclerosis	0.0105	0.0415	CbGpPWpGaD
Felbamate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—amyotrophic lateral sclerosis	0.01	0.0394	CbGpPWpGaD
Felbamate—GRIN2B—brainstem—amyotrophic lateral sclerosis	0.00931	0.0569	CbGeAlD
Felbamate—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—amyotrophic lateral sclerosis	0.0093	0.0366	CbGpPWpGaD
Felbamate—GRIN2B—CREB phosphorylation through the activation of CaMKII—NEFL—amyotrophic lateral sclerosis	0.0093	0.0366	CbGpPWpGaD
Felbamate—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00916	0.0157	CcSEcCtD
Felbamate—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00916	0.0157	CcSEcCtD
Felbamate—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00905	0.0155	CcSEcCtD
Felbamate—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00905	0.0155	CcSEcCtD
Felbamate—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00883	0.0152	CcSEcCtD
Felbamate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—amyotrophic lateral sclerosis	0.0085	0.0335	CbGpPWpGaD
Felbamate—GRIN2A—brainstem—amyotrophic lateral sclerosis	0.00813	0.0498	CbGeAlD
Felbamate—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00783	0.0134	CcSEcCtD
Felbamate—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0129	CcSEcCtD
Felbamate—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0129	CcSEcCtD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—GRIA2—amyotrophic lateral sclerosis	0.00746	0.0294	CbGpPWpGaD
Felbamate—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00739	0.0127	CcSEcCtD
Felbamate—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0124	CcSEcCtD
Felbamate—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0124	CcSEcCtD
Felbamate—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00719	0.0123	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—NEFL—amyotrophic lateral sclerosis	0.00713	0.0281	CbGpPWpGaD
Felbamate—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00712	0.0122	CcSEcCtD
Felbamate—Mania—Riluzole—amyotrophic lateral sclerosis	0.00706	0.0121	CcSEcCtD
Felbamate—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0118	CcSEcCtD
Felbamate—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00682	0.0117	CcSEcCtD
Felbamate—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00682	0.0117	CcSEcCtD
Felbamate—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00682	0.0117	CcSEcCtD
Felbamate—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0115	CcSEcCtD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—GRIA2—amyotrophic lateral sclerosis	0.00634	0.025	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—GRIA2—amyotrophic lateral sclerosis	0.00612	0.0241	CbGpPWpGaD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—NEFL—amyotrophic lateral sclerosis	0.00606	0.0239	CbGpPWpGaD
Felbamate—GRIN2A—Reelin signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00593	0.0234	CbGpPWpGaD
Felbamate—GRIN2A—Post NMDA receptor activation events—NEFL—amyotrophic lateral sclerosis	0.00587	0.0231	CbGpPWpGaD
Felbamate—GRIN2B—spinal cord—amyotrophic lateral sclerosis	0.00579	0.0354	CbGeAlD
Felbamate—GRIN2A—medulla oblongata—amyotrophic lateral sclerosis	0.00567	0.0347	CbGeAlD
Felbamate—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00561	0.00962	CcSEcCtD
Felbamate—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00956	CcSEcCtD
Felbamate—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00937	CcSEcCtD
Felbamate—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00931	CcSEcCtD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—amyotrophic lateral sclerosis	0.00541	0.0213	CbGpPWpGaD
Felbamate—GRIN3A—nervous system—amyotrophic lateral sclerosis	0.00539	0.033	CbGeAlD
Felbamate—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00902	CcSEcCtD
Felbamate—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00897	CcSEcCtD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—GRIA2—amyotrophic lateral sclerosis	0.0052	0.0205	CbGpPWpGaD
Felbamate—GRIN3A—central nervous system—amyotrophic lateral sclerosis	0.00519	0.0318	CbGeAlD
Felbamate—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00881	CcSEcCtD
Felbamate—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00881	CcSEcCtD
Felbamate—GRIN2A—spinal cord—amyotrophic lateral sclerosis	0.00506	0.031	CbGeAlD
Felbamate—GRIN2B—Reelin signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00504	0.0199	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—NEFL—amyotrophic lateral sclerosis	0.00499	0.0197	CbGpPWpGaD
Felbamate—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00496	0.0085	CcSEcCtD
Felbamate—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00496	0.0085	CcSEcCtD
Felbamate—GRIN2B—nervous system—amyotrophic lateral sclerosis	0.00488	0.0298	CbGeAlD
Felbamate—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00827	CcSEcCtD
Felbamate—GRIN2B—central nervous system—amyotrophic lateral sclerosis	0.00469	0.0287	CbGeAlD
Felbamate—Coma—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00805	CcSEcCtD
Felbamate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00796	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.00462	0.0182	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—amyotrophic lateral sclerosis	0.0046	0.0181	CbGpPWpGaD
Felbamate—GRIN2B—cerebellum—amyotrophic lateral sclerosis	0.00459	0.0281	CbGeAlD
Felbamate—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00764	CcSEcCtD
Felbamate—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00764	CcSEcCtD
Felbamate—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00757	CcSEcCtD
Felbamate—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00749	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00735	CcSEcCtD
Felbamate—GRIN2A—nervous system—amyotrophic lateral sclerosis	0.00426	0.0261	CbGeAlD
Felbamate—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00715	CcSEcCtD
Felbamate—GRIN3A—brain—amyotrophic lateral sclerosis	0.00412	0.0252	CbGeAlD
Felbamate—GRIN2A—central nervous system—amyotrophic lateral sclerosis	0.0041	0.0251	CbGeAlD
Felbamate—GRIN2A—cerebellum—amyotrophic lateral sclerosis	0.00401	0.0245	CbGeAlD
Felbamate—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00681	CcSEcCtD
Felbamate—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00675	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.00392	0.0155	CbGpPWpGaD
Felbamate—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00663	CcSEcCtD
Felbamate—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00661	CcSEcCtD
Felbamate—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00655	CcSEcCtD
Felbamate—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00642	CcSEcCtD
Felbamate—GRIN2B—brain—amyotrophic lateral sclerosis	0.00373	0.0228	CbGeAlD
Felbamate—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00639	CcSEcCtD
Felbamate—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00639	CcSEcCtD
Felbamate—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00629	CcSEcCtD
Felbamate—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00629	CcSEcCtD
Felbamate—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00624	CcSEcCtD
Felbamate—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00617	CcSEcCtD
Felbamate—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00608	CcSEcCtD
Felbamate—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00608	CcSEcCtD
Felbamate—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00606	CcSEcCtD
Felbamate—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00601	CcSEcCtD
Felbamate—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00595	CcSEcCtD
Felbamate—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00582	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00576	CcSEcCtD
Felbamate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00566	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00564	CcSEcCtD
Felbamate—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00564	CcSEcCtD
Felbamate—GRIN2A—brain—amyotrophic lateral sclerosis	0.00326	0.0199	CbGeAlD
Felbamate—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00553	CcSEcCtD
Felbamate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00553	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.0032	0.0126	CbGpPWpGaD
Felbamate—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00542	CcSEcCtD
Felbamate—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00525	CcSEcCtD
Felbamate—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00517	CcSEcCtD
Felbamate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00504	CcSEcCtD
Felbamate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00503	CcSEcCtD
Felbamate—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00291	0.005	CcSEcCtD
Felbamate—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00496	CcSEcCtD
Felbamate—Depression—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00491	CcSEcCtD
Felbamate—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0048	CcSEcCtD
Felbamate—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00479	CcSEcCtD
Felbamate—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00472	CcSEcCtD
Felbamate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0047	CcSEcCtD
Felbamate—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00465	CcSEcCtD
Felbamate—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00462	CcSEcCtD
Felbamate—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0046	CcSEcCtD
Felbamate—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0045	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00261	0.0103	CbGpPWpGaD
Felbamate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00445	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.00259	0.0102	CbGpPWpGaD
Felbamate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00443	CcSEcCtD
Felbamate—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00442	CcSEcCtD
Felbamate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00442	CcSEcCtD
Felbamate—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0044	CcSEcCtD
Felbamate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00439	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—ERBB4—amyotrophic lateral sclerosis	0.00255	0.01	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00248	0.00978	CbGpPWpGaD
Felbamate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00418	CcSEcCtD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00243	0.00957	CbGpPWpGaD
Felbamate—Chills—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00397	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00229	0.00903	CbGpPWpGaD
Felbamate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00391	CcSEcCtD
Felbamate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00379	CcSEcCtD
Felbamate—Tension—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00378	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.0022	0.00867	CbGpPWpGaD
Felbamate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00377	CcSEcCtD
Felbamate—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00374	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00211	0.00832	CbGpPWpGaD
Felbamate—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00361	CcSEcCtD
Felbamate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00357	CcSEcCtD
Felbamate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00356	CcSEcCtD
Felbamate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00354	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00202	0.00797	CbGpPWpGaD
Felbamate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00347	CcSEcCtD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00201	0.00793	CbGpPWpGaD
Felbamate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00345	CcSEcCtD
Felbamate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0034	CcSEcCtD
Felbamate—Cough—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00336	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00195	0.00768	CbGpPWpGaD
Felbamate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00332	CcSEcCtD
Felbamate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00328	CcSEcCtD
Felbamate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00328	CcSEcCtD
Felbamate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00328	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.0019	0.0075	CbGpPWpGaD
Felbamate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00327	CcSEcCtD
Felbamate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00324	CcSEcCtD
Felbamate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00321	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00187	0.00735	CbGpPWpGaD
Felbamate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00317	CcSEcCtD
Felbamate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00314	CcSEcCtD
Felbamate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00314	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00183	0.00719	CbGpPWpGaD
Felbamate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00312	CcSEcCtD
Felbamate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00308	CcSEcCtD
Felbamate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00307	CcSEcCtD
Felbamate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00304	CcSEcCtD
Felbamate—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00175	0.0107	CbGeAlD
Felbamate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.003	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00172	0.00679	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00172	0.00678	CbGpPWpGaD
Felbamate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00294	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00286	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00166	0.00655	CbGpPWpGaD
Felbamate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00284	CcSEcCtD
Felbamate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00282	CcSEcCtD
Felbamate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0028	CcSEcCtD
Felbamate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00279	CcSEcCtD
Felbamate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00277	CcSEcCtD
Felbamate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00273	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00159	0.00625	CbGpPWpGaD
Felbamate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00271	CcSEcCtD
Felbamate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00269	CcSEcCtD
Felbamate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00269	CcSEcCtD
Felbamate—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00156	0.00953	CbGeAlD
Felbamate—GRIN2B—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00155	0.00611	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00152	0.00599	CbGpPWpGaD
Felbamate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00259	CcSEcCtD
Felbamate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00257	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00146	0.00577	CbGpPWpGaD
Felbamate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0025	CcSEcCtD
Felbamate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00248	CcSEcCtD
Felbamate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00248	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00143	0.00563	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00141	0.00557	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00141	0.00557	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00141	0.00557	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00136	0.00536	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00132	0.0052	CbGpPWpGaD
Felbamate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00225	CcSEcCtD
Felbamate—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00131	0.00803	CbGeAlD
Felbamate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00222	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00129	0.0051	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00127	0.00502	CbGpPWpGaD
Felbamate—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00773	CbGeAlD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00126	0.00497	CbGpPWpGaD
Felbamate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00215	CcSEcCtD
Felbamate—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00123	0.00755	CbGeAlD
Felbamate—GRIN2B—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00122	0.00479	CbGpPWpGaD
Felbamate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00208	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00121	0.00476	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0012	0.00474	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0012	0.00474	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00117	0.00459	CbGpPWpGaD
Felbamate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00116	0.002	CcSEcCtD
Felbamate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00198	CcSEcCtD
Felbamate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00198	CcSEcCtD
Felbamate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00197	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00113	0.00444	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00112	0.00442	CbGpPWpGaD
Felbamate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00187	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00427	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00108	0.00427	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00108	0.00427	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00107	0.00423	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00107	0.00422	CbGpPWpGaD
Felbamate—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00106	0.00646	CbGeAlD
Felbamate—GRIN2B—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00103	0.00405	CbGpPWpGaD
Felbamate—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00102	0.00622	CbGeAlD
Felbamate—CYP2E1—brain—amyotrophic lateral sclerosis	0.001	0.00614	CbGeAlD
Felbamate—GRIN2B—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000991	0.00391	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000966	0.00381	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000931	0.00367	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000922	0.00363	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000922	0.00363	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000821	0.00324	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000809	0.00319	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000769	0.00303	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000684	0.00269	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000665	0.00262	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000654	0.00257	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000631	0.00248	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000538	0.00212	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.000537	0.00212	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000493	0.00194	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000486	0.00192	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000483	0.0019	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000419	0.00165	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000404	0.00159	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000375	0.00148	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000343	0.00135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000318	0.00125	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000303	0.00119	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000299	0.00118	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000293	0.00115	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000282	0.00111	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000278	0.0011	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000218	0.000858	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000216	0.000852	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000216	0.000852	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000215	0.000846	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000205	0.000809	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.0002	0.000787	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000198	0.000779	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000184	0.000724	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000179	0.000707	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000173	0.000681	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000167	0.000657	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000167	0.000657	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000156	0.000616	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000156	0.000613	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000153	0.000601	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000143	0.000561	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000142	0.000559	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000133	0.000525	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000516	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000129	0.000509	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000128	0.000504	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000121	0.000475	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000118	0.000467	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000109	0.000431	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0001	0.000395	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0001	0.000395	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	9.17e-05	0.000361	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	9.14e-05	0.00036	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.98e-05	0.000354	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.53e-05	0.000336	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	8.44e-05	0.000332	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.02e-05	0.000316	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.68e-05	0.000303	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.25e-05	0.000286	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	6.93e-05	0.000273	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.32e-05	0.000249	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.5e-05	0.000217	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.07e-05	0.0002	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-05	0.00019	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.43e-05	0.000175	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.33e-05	0.000171	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.17e-05	0.000164	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.72e-05	0.000147	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	3.65e-05	0.000144	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.42e-05	0.000135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.81e-05	0.000111	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-05	9.85e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.24e-05	8.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	8.11e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.93e-05	7.6e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.69e-05	6.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	4.57e-05	CbGpPWpGaD
